Latest Reports 
Results,Reports And Presentations £59.6m Revenue (2022: £72.8m)
£(14.8)m Operating loss excluding R&D and exceptionals (2022: £3.4m operating profit excluding R&D)
£(43.1)m Net loss after tax (2022: £(13.8)m net loss after tax)
Allergies reduce quality of life by preventing individuals and their loved ones from enjoying the everyday activities most take for granted. At their most severe, they can be fatal.
Transforming lives
Specialist expertise drives and inspires us to discover more, helping us to improve patients' lives.
Specialist expertise
To achieve our vision and fulfil our mission, we develop treatments that are as convenient as they are effective.
Delivering convenience
Take your career to new heights
Career Vacancies